Assertio Therapeutics Inc (NQ: ASRT )
5.820 -0.110 (-1.85%) Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
All News about Assertio Therapeutics Inc
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From MicroCap Rodeo
Sidoti May Virtual Micro Cap Investor Conference
May 10, 2022
- Presentation Times and Weblinks Released for Over 60 Presenting Companies - Wednesday and Thursday, May 11th-12th, 2022 NEW YORK, NY / ACCESSWIRE / May 10, 2022 / Sidoti & Company, LLC has released...
103 Biggest Movers From Yesterday
May 11, 2022
77 Stocks Moving In Tuesday's Mid-Day Session
May 10, 2022
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
March 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus AbbVie Settles With Alvotech On Humira Biosimilar Patent Dispute AbbVie, Inc...
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
NASDAQ: ASRT Investor Alert: Investigation Concerning Possible Wrongdoing at Assertio Holdings, Inc.
February 25, 2022
San Diego, CA -- (SBWIRE) -- 02/25/2022 -- An investigation on behalf of investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares over potential wrongdoing at Assertio Holdings, Inc. was announced.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following